MTOR and Alzheimer disease: Clinically, increased IL-37 expression was detectable in the skin lesions and serum of AD patients (Fujita et al., 2013), whereas IL-37 could attenuate inflammation symptoms, eliminate eosinophil infiltration, and increase Treg cells through the AMPK/mTOR signaling (Hou et al., 2020).